Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30001670HIVENSG00000198734.12protein_codingF5NoNo2153P12259
TVIS20014099HPVENSG00000198734.12protein_codingF5NoNo2153P12259
TVIS20045389HPVENSG00000198734.12protein_codingF5NoNo2153P12259
TVIS20068815HPVENSG00000198734.12protein_codingF5NoNo2153P12259
TVIS44029608HTLV-1ENSG00000198734.12protein_codingF5NoNo2153P12259
TVIS44021688HTLV-1ENSG00000198734.12protein_codingF5NoNo2153P12259
TCGA Plot Options
Drug Information
GeneF5
DrugBank IDDB00055
Drug NameDrotrecogin alfa
Target IDBE0000041
UniProt IDP12259
Regulation Typeinhibitor
PubMed IDs11236773; 11714212; 11893230; 12004250; 12030642; 11752352; 6419799
CitationsBernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 Mar 8;344(10):699-709.@@Kanji S, Devlin JW, Piekos KA, Racine E: Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis. Pharmacotherapy. 2001 Nov;21(11):1389-402.@@Lyseng-Williamson KA, Perry CM: Drotrecogin alfa (activated). Drugs. 2002;62(4):617-30; discussion 631-2.@@Joyce DE, Grinnell BW: Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappaB. Crit Care Med. 2002 May;30(5 Suppl):S288-93.@@Poe K: Drotrecogin alfa (activated) approved for treatment of severe sepsis. J Am Pharm Assoc (Wash). 2002 May-Jun;42(3):520-2.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS: Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. Blood. 1984 Feb;63(2):486-9.
GroupsApproved; Investigational; Withdrawn
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA131548935
ChEMBL